Breaking News

Fujifilm Invests $188M in New Cell Culture Media Manufacturing Facility

Triples the company’s current capacity for liquid cell culture media production.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Fujifilm Corporation announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), NC. The new site will be operated by Fujifilm Irvine Scientific, Inc., a subsidiary of Fujifilm Corporation, and a leader in the development and manufacture of advanced cell culture solutions for life science research, bioproduction, cell therapy manufacturing, and medical applications. The new facility is planned to ensure that Fujifilm Irvine Scient...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters